Dolan Matthew Vincent
- SEC CIK
- 0001914994
No open-market purchases or sales filed in the past year.
Current role at each company
- DXCM Dexcom IncEVP, Strategy & Corporate Devas of Jan 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dolan Matthew Vincent as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 (view filing) | Jan 29 | 1 day | Dolan Matthew VincentEVP, Strategy & Corporate Dev | SSale | −1.18K | $86.91 | −$102.8K | −2.7%42.0K after | |
| May 16, 2024 (view filing) | May 15 | 1 day | Dolan Matthew VincentEVP Strategy and Corporate Dev | SSale | −2.42K | $126.58 | −$306.7K | −5.7%40.1K after | 10b5-1 |
| Apr 16, 2024 (view filing) | Apr 15 | 1 day | Dolan Matthew VincentEVP Strategy and Corporate Dev | SSale | −1.99K | $137.81 | −$274.2K | −4.5%42.4K after | 10b5-1 |
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Dolan Matthew VincentEVP Strategy & Corp Dev | SSale | −4.20K | $130.20 | −$547.2K | −8.7%44.4K after | 3 lots10b5-1 |
| Mar 14, 2024 (view filing) | Mar 12 | 2 days | Dolan Matthew VincentEVP Strategy and Corporate | SSale | −6.71K | $134.41 | −$901.9K | −12.1%48.6K after | |
| Sep 1, 2023 (view filing) | Sep 1 | Same day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −56 | $102.32 | −$5.73K | −0.2%33.6K after | |
| Mar 17, 2023 (view filing) | Mar 16 | 1 day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −2.30K | $115.00 | −$264.8K | −6.4%33.6K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −6.23K | $106.27 | −$662.0K | −14.8%35.9K after | |
| Mar 6, 2023 (view filing) | Mar 6 | Same day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −226 | $114.40 | −$25.9K | −0.8%26.5K after | |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −5 | $81.63 | −$408.15 | 0.0%26.5K after | |
| Mar 17, 2022 (view filing) | Mar 15-17 | 2 days | Dolan Matthew VincentSVP Corporate Development | SSale | −2.19K | $424.68 | −$928.4K | −24.8%6.63K after | 3 lots |